Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Interleukin 15 Receptor Beta Chain (IL-15Rβ) is a component of the receptor complexes for both interleukin-15 (IL-15) and interleukin-2 (IL-2). It is shared with the IL-2 receptor complex and is critical for signal transduction, playing key roles in lymphocyte proliferation, NK-cell maturation, memory CD8+ T-cell maintenance, and inflammatory responses. It signals through the JAK/STAT, PI3K/Akt/mTOR, and MAPK pathways. It is a therapeutic target for cancer immunotherapy, where IL-15 superagonists are being explored.
Agonist; Receptor subunit involved in signal transduction via JAK/STAT, PI3K/Akt/mTOR, and MAPK pathways
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interleukin 15 Receptor Beta Chain (IL-15Rβ).